Rauhala HE - Search Results

1

TCEB1 promotes invasion of prostate cancer cells.

Jalava SE, Porkka KP, Rauhala HE, Isotalo J, Tammela TL, Visakorpi T. Jalava SE, et al. Among authors: rauhala he. Int J Cancer. 2009 Jan 1;124(1):95-102. doi: 10.1002/ijc.23916. Int J Cancer. 2009. PMID: 18844214

2

Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.

Rauhala HE, Porkka KP, Tolonen TT, Martikainen PM, Tammela TL, Visakorpi T. Rauhala HE, et al. Int J Cancer. 2005 Dec 10;117(5):738-45. doi: 10.1002/ijc.21270. Int J Cancer. 2005. PMID: 15981206

3

Clusterin is epigenetically regulated in prostate cancer.

Rauhala HE, Porkka KP, Saramäki OR, Tammela TL, Visakorpi T. Rauhala HE, et al. Int J Cancer. 2008 Oct 1;123(7):1601-9. doi: 10.1002/ijc.23658. Int J Cancer. 2008. PMID: 18649357

4

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, Tammela TL, Oja H, Visakorpi T. Rauhala HE, et al. Int J Cancer. 2010 Sep 1;127(6):1363-72. doi: 10.1002/ijc.25162. Int J Cancer. 2010. PMID: 20073067

5

KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro.

Laurila E, Vuorinen E, Savinainen K, Rauhala H, Kallioniemi A. Laurila E, et al. Exp Cell Res. 2014 Mar 10;322(1):159-67. doi: 10.1016/j.yexcr.2013.11.014. Epub 2013 Nov 23. Exp Cell Res. 2014. PMID: 24275456

6

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.

Kaukoniemi KM, Rauhala HE, Scaravilli M, Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL, Visakorpi T. Kaukoniemi KM, et al. Among authors: rauhala he. Cancer Med. 2015 Sep;4(9):1417-25. doi: 10.1002/cam4.486. Epub 2015 Jul 1. Cancer Med. 2015. PMID: 26129688 Free PMC article.

7

Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen.

Kukkonen K, Autio-Kimura B, Rauhala H, Kesseli J, Nykter M, Latonen L, Visakorpi T. Kukkonen K, et al. Endocr Relat Cancer. 2022 Nov 7;29(12):717-733. doi: 10.1530/ERC-22-0108. Print 2022 Dec 1. Endocr Relat Cancer. 2022. PMID: 36219867 Free PMC article.

8

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.

Sattari M, Kohvakka A, Moradi E, Rauhala H, Urhonen H, Isaacs WB, Nykter M, Murtola TJ, Tammela TLJ, Latonen L, Bova GS, Kesseli J, Visakorpi T. Sattari M, et al. Endocr Relat Cancer. 2023 Jun 26;30(8):e220247. doi: 10.1530/ERC-22-0247. Print 2023 Aug 1. Endocr Relat Cancer. 2023. PMID: 37140987 Free PMC article.

9

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Nurminen A, Jaatinen S, Taavitsainen S, Högnäs G, Lesluyes T, Ansari-Pour N, Tolonen T, Haase K, Koskenalho A, Kankainen M, Jasu J, Rauhala H, Kesäniemi J, Nikupaavola T, Kujala P, Rinta-Kiikka I, Riikonen J, Kaipia A, Murtola T, Tammela TL, Visakorpi T, Nykter M, Wedge DC, Van Loo P, Bova GS. Nurminen A, et al. Genome Med. 2023 Oct 12;15(1):82. doi: 10.1186/s13073-023-01242-y. Genome Med. 2023. PMID: 37828555 Free PMC article.

10

Silencing of the ARP2/3 complex disturbs pancreatic cancer cell migration.

Rauhala HE, Teppo S, Niemelä S, Kallioniemi A. Rauhala HE, et al. Anticancer Res. 2013 Jan;33(1):45-52. Anticancer Res. 2013. PMID: 23267127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters